Patents by Inventor Egbert G. Mik

Egbert G. Mik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230172501
    Abstract: The disclosure relates to methods and devices for monitoring the concentration of a substance, preferably oxygen, in a cell or tissue, e.g., in cells of the human skin. In particular, it provides a method for determining the concentration of a quencher, such as oxygen and/or the concentration of a probe, e.g., a heme precursor such as protoporphyrin IX (PpIX), wherein the probe is capable of exhibiting luminescence (delayed fluorescence (DF) or phosphorescence) and or transient triplet absorption, preferably, deDF, in a living cell. The method comprises steps of exciting the probe, measuring the lifetime of the luminescence exhibited by said probe, herein, in the presence of the quencher, the lifetime is shortened as compared to the lifetime in the absence of the quencher, and correlating said lifetime with said concentration.
    Type: Application
    Filed: May 21, 2021
    Publication date: June 8, 2023
    Inventors: Gauthier CROIZAT, Egbert G. MIK, Georges WAGNIÉRES, Emmanuel GERELLI
  • Patent number: 10920260
    Abstract: Mitochondrial function is measured. Repetitive or continuous measurements are performed of prompt red fluorescence, emerging from the skin due to PpIX build up, and/or delayed fluorescence of PpIX. An estimate of the rate of PpIX generation is used as an indicator of mitochondrial integrity and ATP availability. Mitochondrial oxygen tension is determined from the delayed fluorescence lifetime of PpIX. When blood supply to the measurement volume is interrupted or reduced, the resulting changes to the mitochondrial oxygen tension allow an estimation of information about the kinetics of oxygen consumption in the mitochondria, such as the maximum rate of oxygen consumption as well as the Michaelis-Menten constant, providing information about the oxygen affinity of the mitochondrial respiratory chain.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: February 16, 2021
    Assignee: Erasmus University Medical Center Rotterdam
    Inventor: Egbert G. Mik
  • Patent number: 8008038
    Abstract: Described are methods and devices for determining a concentration of oxygen in a compartment comprising exciting protoporphyrin IX.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: August 30, 2011
    Assignee: Academisch Medicsh Centrum bij de Universiteit van Amsterdam
    Inventors: Egbert G. Mik, Michiel Sinaasappel
  • Publication number: 20110182825
    Abstract: Mitochondrial function is measured. Repetitive or continuous measurements are performed of prompt red fluorescence, emerging from the skin due to PpIX build up, and/or delayed fluorescence of PpIX. An estimate of the rate of PpIX generation is used as an indicator of mitochondrial integrity and ATP availability. Mitochondrial oxygen tension is determined from the delayed fluorescence lifetime of PpIX. When blood supply to the measurement volume is interrupted or reduced, the resulting changes to the mitochondrial oxygen tension allow an estimation of information about the kinetics of oxygen consumption in the mitochondria, such as the maximum rate of oxygen consumption as well as the Michaelis-Menten constant, providing information about the oxygen affinity of the mitochondrial respiratory chain.
    Type: Application
    Filed: August 14, 2009
    Publication date: July 28, 2011
    Inventor: Egbert G. Mik
  • Publication number: 20100255523
    Abstract: Described are methods for determining a concentration of a substance in a compartment comprising exciting an endogenous compound, or a functional part, derivative, analogue or precursor thereof, measuring the lifetime of the luminescence and/or transient absorption exhibited by the compound, functional part, derivative, analogue and/or precursor, and correlating the lifetime with the concentration of the substance.
    Type: Application
    Filed: September 10, 2009
    Publication date: October 7, 2010
    Applicant: Academisch Medisch Centrum BIJ De Universiteit Van Amsterdam
    Inventors: Egbert G. Mik, Michiel Sinaasappel